These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11904860)
21. Sumatriptan. An updated review of its use in migraine. Perry CM; Markham A Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601 [TBL] [Abstract][Full Text] [Related]
22. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [TBL] [Abstract][Full Text] [Related]
23. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients]. Géraud G; Valette C Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800 [TBL] [Abstract][Full Text] [Related]
24. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796 [TBL] [Abstract][Full Text] [Related]
25. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials. Tfelt-Hansen P Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070 [TBL] [Abstract][Full Text] [Related]
26. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects. Boska MD; Welch KM; Schultz L; Nelson J Cephalalgia; 2000 Feb; 20(1):39-44. PubMed ID: 10817445 [TBL] [Abstract][Full Text] [Related]
27. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167 [TBL] [Abstract][Full Text] [Related]
28. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662 [TBL] [Abstract][Full Text] [Related]
29. Cerebral vasospasm from sumatriptan. Dash S; Bogdanova O; Xavier A; Farkas J; Pullicino P Neurology; 2004 Dec; 63(11):2128. PubMed ID: 15596760 [No Abstract] [Full Text] [Related]
31. Effects of medication use on health state in postictal migraineurs. Mulder EJ; Passchier J; Linssen WH; de Geus EJ Headache; 2001 Sep; 41(8):782-91. PubMed ID: 11576203 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of migraine in patients with hypertension and ischemic heart disease]. Ficzere A; Csiba L Ideggyogy Sz; 2002 Jan; 55(1-2):25-9. PubMed ID: 12122940 [TBL] [Abstract][Full Text] [Related]
34. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study. Putnam GP; O'Quinn S; Bolden-Watson CP; Davis RL; Gutterman DL; Fox AW Cephalalgia; 1999 Sep; 19(7):668-75. PubMed ID: 10524661 [TBL] [Abstract][Full Text] [Related]